Industry Innovators

Sunday , 24 March 2024

Time: 12.35 - 12.55 pm Theatrette 1 (Exhibition Hall)

Synopsis: Optimal diagnosis and management of progressive fibrosing interstitial lung diseases (PF-ILDs) requires a multidisciplinary approach. These educational sessions will be presented in a mock multidisciplinary team (MDT) format and feature experts in ILD including respiratory physicians and a thoracic radiologist. The diagnostic and management process for PF-ILD will be discussed through case-based discussions, focussing on identifying radiological features of various ILDs and aid in the prompt diagnosis and optimal management of progressively fibrosing ILDs.

Time: 12.10 - 12.35 pm Theatrette 2 (Exhibition Hall)

Synopsis: Reshaping respiratory health with mRNA medicines: COVID-19 and beyond

 

Time: 12.35 - 12.55 pm Theatrette 2 (Exhibition Hall)

Synopsis: Reshaping respiratory health with mRNA medicines: COVID-19 and beyond

 

Monday, 25 March 2024

Asthma clinical remission - from inhaled therapies to biologics: can it be achieved? 

Speaker: Prof. Peter Gibson

Time: 12.10 - 12.30 pm Theatrette 1 (Exhibition Hall)

Synopsis: Clinical remission is emerging as an important treatment goal for patients with asthma, irrespective of their disease severity and current treatments. In this session, Prof. Peter Gibson (respiratory physician at John Hunter hospital and professor at the University of Newcastle, NSW) will discuss developing frameworks and definitions for asthma remission, further recent evidence on the role of biologics and new evidence on the role of single inhaler triple therapy in attaining on-treatment remission in asthma.

 

Time: 12.35 - 12.55 pm Theatrette 1 (Exhibition Hall)

Synopsis: Optimal diagnosis and management of progressive fibrosing interstitial lung diseases (PF-ILDs) requires a multidisciplinary approach. These educational sessions will be presented in a mock multidisciplinary team (MDT) format and feature experts in ILD including respiratory physicians and a thoracic radiologist. The diagnostic and management process for PF-ILD will be discussed through case-based discussions, focussing on identifying radiological features of various ILDs and aid in the prompt diagnosis and optimal management of progressively fibrosing ILDs.

Patient first: innovation in environmentally responsible inhaled therapy with Prof Dave Singh

Time: 12.35 - 12.55 pm Theatrette 2 (Exhibition Hall)

Synopsis: Patient first. This principle lies at the heart of modern medicine. To ensure clinicians’ ability to provide this, innovations in new carbon minimal formulations of pressurised metered dose inhalers (pMDI) for asthma and COPD are well underway.

F-gases are a minor but potent greenhouse gas used in refrigeration and as propellants in currently available pMDIs. Learn about developments of a new generation of propellants, the implications for inhaled therapies in a carbon constrained future and balancing care for patients and the environment.

Because the best inhaler is the one a patient can and will use. 

Tuesday, 26 March 2024 

Optimising Nicotine Replacement Therapy

Time: 12.10 - 12.35 pm Theatrette 1 (Exhibition Hall)

Speaker: Henry Marshall 

Synopsis: Despite the accessibility of Nicotine replacement therapy (NRT), quitters frequently use sub-optimally. This session will discuss common pitfalls when using NRT, and how to re-engage patients to attempt another quit attempt successfully.

Optimising Nicotine Replacement Therapy

Time: 12.35 - 12.55 pm Theatrette 1 (Exhibition Hall)

Speaker: Henry Marshall 

Synopsis: Despite the accessibility of Nicotine replacement therapy (NRT), quitters frequently use sub-optimally. This session will discuss common pitfalls when using NRT, and how to re-engage patients to attempt another quit attempt successfully.

Key Dates

TSANZSRS ASM 2025
21 - 25 March 2025
Adelaide Convention Centre